ClinicalTrials.gg
RecruitingNCT05383963Updated Dec 1, 2025

Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome

An observational study in Sepsis and Septic Shock, sponsored by Charite University, Berlin, Germany. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-01.

Primary conditionShock, SepticRegistry: SepsisReclassifiedWhy we changed it
Registry
Sepsis — the first condition term the registry derived for this study.
ClinicalTrials.gg
Shock, Septic
Why
  1. The study's listed conditions name Shock, Septic, a narrower term within Sepsis.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Charite University, Berlin, Germany · Observational

How we know

From the registry’s dates

  • Started Jul 2022; still recruiting 4 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
10,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 56 studies in Shock, Septic with a site in Germany — 7 open to participants now, 7 under way, none of them phase 3. Shock, Septic · Germany.

Planned enrollment
Largest of 26
10,000 · median 275
Started
2022
with 4 others
Observational
27 of 56
5 open now
Registered
51st of 56
by date
Lead sponsor
2 of 56
Charite University, Berlin, Germany

Among the 56 studies in Shock, Septic with a site in Germany, this one has the largest planned enrollment of the 26 observational ones that give a count, is one of 5 that started in 2022, is one of 27 observational ones, and was the 51st registered.

Shock, Septic

1,084 studies on the registry are indexed under Shock, Septic; 236 are open to participants now.

Browse Shock, Septic studies →

Open to participants now

7 of the 56 studies in Shock, Septic with a site in Germany are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 137 Shock, Septic studies recruiting now, 103 (75%) set no upper age limit and 18 (13%) stop at 75 or younger; 11 take children under 18; 14 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 56 studies in Shock, Septic with a site in Germany, or all of them as a file.
02

Study summary

Retrospective observational study to develop a Machine Learning Algorithm to evaluate parameters collected from routine data for the diagnosis of sepsis and septic shock and their influence on time to diagnosis and patient outcome.

Read the detailed description

Retrospective routine data from the medical records of the department of anesthesiology and operative intensive care from 01. 01. 2007 to 31. 12. 2021 are analyzed in digital form.

The first step is the development of a machine learning algorithm (MLA). This MLA will be validated and analyzed for his predictive value with regard to early diagnosis of sepsis/septic shock depending on the conceptual value of detection variables (Sepsis-3 vs. SIRS). Further analysis will focus on improvement of accuracy for the MLA and the effect of these detection variables on quality of treatment processes and also on economic consequences like cost and revenue.

Timeline:

  1. Conception and development of the ML Algorithm (6 months)
  2. Identification and diagnostic validation of sepsis patients (6 months)
  3. Secondary analyses (36 months)
03

Conditions studied

  • Sepsis
  • Septic Shock

Browse trials for

04

In context

Shock, Septic Reclassified

1,084 studies on the registry are indexed under Shock, Septic; 236 are open to participants now.

This study's planned enrollment of 10,000 is above the median of 108 across 408 observational studies indexed under Shock, Septic.

Browse Shock, Septic studies →

Lead sponsor

Charite University, Berlin, Germany is the lead sponsor of 857 studies on the registry; 128 are open to participants now.

Compared within Shock, Septic, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Sepsis. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Intensive care unit patients (female, male, miscellaneous) from the age of 18 years with an intensive care stay of > 24 hours in an intensive care unit since 01. 01. 2007 from the Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age >= 18 years
  • ICU stay of > 24 hours

Exclusion criteria

Exclusion Criteria:

  • none
06

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
10,000 participants (estimated)
Patient registry
No
07

What researchers measure

Primary outcomes

  1. Sepsis/septic shock

    Development of a machine learning algorithm (MLA) for the prediction of sepsis/septic shock from hospital routine data.

    Time frame: 01.01.2007 -31.12.2021

Secondary outcomes

  1. Predictive accuracy

    Evaluation of the predictive accuracy (= predictive value) of the respective sepsis diagnostic algorithm (i.e. comparison of the concepts SIRS and Sepsis-3)

    Time frame: 01.01.2007 -31.12.2021

  2. Diagnostic accuracy

    Identification of additional variables for diagnostic accuracy (laboratory values, clinical parameters and vital-sign monitor parameters and other relevant health data

    Time frame: 01.01.2007 -31.12.2021

  3. Performance indicators

    Evaluation of performance indicators of clinical routine processes (Intensive care quality indicators)

    Time frame: 01.01.2007 -31.12.2021

  4. Case costs

    Case costs related to hospitalization

    Time frame: 01.01.2007 -31.12.2021

  5. Revenues

    Revenues related to hospitalization

    Time frame: 01.01.2007 -31.12.2021

08

Study locations

1 of 1 sites recruiting
  • Department of Anesthesiology and Operative Intensive Care Medicine CCM/CVK, Charité - Universitätsmedizin Berlin
    Berlin, 13353, Germany
    Recruiting
    • Claudia Spies, MD, Prof. · Contactclaudia.spies@charite.de · +49 30 450 55 11 02
    • Claudia Spies, MD, Prof. · Principal investigator
    • Oliver Kumpf, MD · Sub investigator
    • Andreas Edel, MD · Sub investigator
    • Carolin Steffen, MD · Sub investigator
    • Fabian Schreiber, MD · Sub investigator
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2022 (actual). Primary completion is estimated for Sep 2026, 50 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 17, 2022
First posted
May 20, 2022
StartActual
Jul 15, 2022
Primary completionEst.
Sep 2026
CompletionEst.
Dec 2027
Last update
Dec 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05383963
Responsible party
Claudia Spies (Head of the Department of Anesthesiology and Operative Intensive Care Medicine CCM/CVK, Charité - Universitätsmedizin Berlin, Charite University, Berlin, Germany) — Principal investigator
First posted
May 20, 2022
Start date
Jul 15, 2022
Primary completion
Sep 2026 (estimated)
Completion
Dec 2027 (estimated)
Last update
Dec 1, 2025

Study contacts

Claudia Spies, MD, Prof.
Contact
claudia.spies@charite.de
+49 30 450 55 11 02
Claudia Spies, MD, Prof.
study director · Charite University, Berlin, Germany

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion